US Patent Issued to UNIVERSITAT ZURICH on Aug. 12 for "Ligands to GM-CSF or GM-CSF-receptor for use in leukemia in a patient having undergone allo-HCT" (Swiss Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,384,839, issued on Aug. 12, was assigned to UNIVERSITAT ZURICH (Zurich).

"Ligands to GM-CSF or GM-CSF-receptor for use in leukemia in a patient having undergone allo-HCT" was invented by Burkhard Becher (Maur, Switzerland) and Sonia Tugues (Zurich).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein is the use of a non-agonist ligand, particularly an antibody, specifically binding to GM-CSF or one of CD116, CD131 and the GM-CSF receptor composed of CD116 and CD131 for use in treatment of leukemia in a patient having undergone allo-HCT or in treatment of other complications arising as a consequence of hematopoietic cell transplantation from an...